drugset / Trial / NCT02855788

Metronomic Chemotherapy in Advanced Gastric Cancer

NCT02855788 ↗

NaSingle-groupOpen-labelTreatment

Summary

phase II study of weekly metronomic chemotherapy using weekly Paclitaxel, Oxaliplatin, Leucovorin and 5-FU (POLF) in patients with advanced gastric cancer

Timeline

Start
2015-05
Primary completion
2018-07
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule 20 mg/m2 Intravenous
Subject Oxaliplatin Small molecule 50 mg/m2 Intravenous
Subject Paclitaxel Small molecule 60 mg/m2 Intravenous
Subject fluorouracil Small molecule 425 mg/m2 Intravenous

Indications